Inge Lodewijckx

Inge Lodewijckx

UNVERIFIED PROFILE

Are you Inge Lodewijckx?   Register this Author

Register author
Inge Lodewijckx

Inge Lodewijckx

Publications by authors named "Inge Lodewijckx"

Are you Inge Lodewijckx?   Register this Author

3Publications

39Reads

8Profile Views

Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.

Sci Transl Med 2017 04;9(385)

Laboratory of Tumor Microenvironment and Therapeutic Resistance, VIB-Center for Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aak9679DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554432PMC
April 2017